These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21843059)

  • 1. Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle.
    Bocci G; Loupakis F
    Pharmacogenomics; 2011 Aug; 12(8):1077-80. PubMed ID: 21843059
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
    Grothey A; Ellis LM
    Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new weapon for attacking tumor blood vessels.
    Semenza GL
    N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385
    [No Abstract]   [Full Text] [Related]  

  • 4. [New medications; bevacizumab].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors.
    Wong H; Yau T; Man CW; Epstein RJ
    Acta Oncol; 2009; 48(8):1213-5. PubMed ID: 19863234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-angiogenetic agents for solid tumors].
    Blay JY
    Rev Med Interne; 2007 Jun; 28 Suppl 1():S7-8. PubMed ID: 17482319
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 8. Bevacizumab for advanced breast cancer.
    Traina TA; Rugo HS; Dickler M
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic agents in breast cancer.
    Salter JT; Miller KD
    Cancer Invest; 2007 Oct; 25(7):518-26. PubMed ID: 18027149
    [No Abstract]   [Full Text] [Related]  

  • 10. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
    Jayson G; Armand JP; Berdel WE
    Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
    [No Abstract]   [Full Text] [Related]  

  • 12. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of angiogenesis inhibitors in the treatment of colorectal cancer].
    Bodoky G
    Magy Onkol; 2007; 51(2):139-44. PubMed ID: 17660870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances of VEGF related molecular promoting tumor angiogenesis and targeting therapy].
    Guo ZY; Cao BL
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):282-4. PubMed ID: 20654135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of vascular endothelial growth factor genetic variability in cancer.
    Schneider BP; Radovich M; Miller KD
    Clin Cancer Res; 2009 Sep; 15(17):5297-302. PubMed ID: 19706811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiogenesis - still a worthwhile target for breast cancer therapy?
    Lord S; Harris AL
    Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S19. PubMed ID: 21172081
    [No Abstract]   [Full Text] [Related]  

  • 20. Bevacizumab (Avastin).
    Mukherji SK
    AJNR Am J Neuroradiol; 2010 Feb; 31(2):235-6. PubMed ID: 20037132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.